Scientists from Imperial College London, UK, have revealed that a clinical trial to treat anxiety with magic mushrooms has been a great success, raising hopes that it could be the solution for individuals struggling with anxiety.
The outcome of the research study have been released in the journal Lancet Psychiatry. The research study was moneyed by the British Medical Research study Council (MRC).
According to the research study, the magic mushrooms utilized in the scientific trial were highly effective against depression in volunteers who participated in the research study. Although the sample size utilized in the study was small, the researchers stated the outcomes showed that the mushrooms could be extremely effective when treating depression.
The researchers say that the trial took years and substantial money to complete due to the strict regulatory restrictions involved with class A drugs. Class A drugs are drugs that have high abuse capacity, no medical usage, and severe security issues. In the UK and some countries, magic mushrooms are classified as a class A drug.
Under the United Nations 1971 Convention on Psychotropic Substances, magic mushrooms are noted as a class 1 drug. Nevertheless, magic mushrooms have actually had many medicinal and religious usages in numerous cultures throughout history. Magic mushrooms also have a considerably lower capacity for abuse than other narcotic drugs.
The researchers composed in the research that two dosages of psilocybin, the active substance in the mushrooms, sufficed to lift depression in all 12 volunteers for 3 weeks, and to keep it away in five of them for three months.
The scientists revealed that the volunteers who participated had severe depression and had not been able to improve on the least two regular antidepressants. They were at first provided a low dose of psilocybin to ensure they had no negative responses; a greater dose was provided a week later on. None of the individuals revealed any negative reactions. They were then dealt with in a specifically ready space, with music playing and in the existence of two psychiatrists who talked with them throughout. It is said the psychedelic experience lasted up to five hours.
An individual of the research study called Kirk Rutter, explained he’s heartbroken by the death of his mother and was unable to come to terms with it despite the counselling and medication he got. He said he was unsure about taking part in the study since he had actually never taken magic mushrooms, however the friendly personnel, the room layout and the music had unwounded him by the time he was ready to swallow the capsules.
It took 30 months for the researchers to obtain the drug, which had to be specially packaged into capsules for the trial by a business which was needed to get a licence to do so. The researchers stated all the governing approvals took 32 months, and it cost ₤ 1,500 to dose each person. But the researchers believe when the drug is authorized for the public, it will cost around ₤ 30.
The scientists said they will encourage the MRC or other funders to raise the funds required for a full trial, since of the initial outcomes shown by the clinical trial.
The researchers stated they do not know how the mushrooms treated the depression. They asserted that it might be by the chemical changes in the brain or the psychedelic experience. But some people believe the psychedelic experience is a spiritual process that heals people of the mental troubles they are going through.
Despite of the research study's appealing outcomes, the scientists cautioned people not to attempt magic mushrooms themselves, as it could be incredibly hazardous.
The Guardian quoted the lead author of the study, Dr Robin Carhart-Harris, as stating:“Psychedelic drugs have potent psychological effects and are only given in our research when appropriate safeguards are in place, such as careful screening and professional therapeutic support. I wouldn’t want members of the public thinking they can treat their own depressions by picking their own magic mushrooms. That kind of approach could be risky.”
Thanks for taking the time to read this article. If you found this information helpful, please share it with your friends and family. Your support in our endeavor of sharing free information would be much appreciated.
You have permission to republish this article under a Creative Commons license with attribution to Deprogram Yourself